Improved strength and functional abilities following IV immunoglobulin treatment for chronic dermatomyositis is reported in two children from the University of Mississippi Medical Center, Jackson, MS
This thesis describes studies in the field of juvenile dermatomyositis (JDM), a chronic inflammatory...
Juvenile dermatomyositis is an autoimmune disease seen in children, which causes typical skin change...
The objective of this study is to describe the benefit of 20 % subcutaneous infusions of immunoglobu...
juvenile dermatomyositis is a chronic multisystemic disease. It is believed to be of autoimmune aeti...
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease, which usually presents wit...
Objective. Juvenile dermatomyositis (DM) is a chronic inflammatory myopathy of childhood primarily a...
The case of a 56-year-old woman, with a previous history of systemic lupus erythematosus (SLE), late...
The impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clin...
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already o...
The myositis syndromes include polymyositis, dermatomyositis (DM), necrotizing myopathy, inclusion b...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
To report clinical and immunologic aspects of a case with inclusion body myositis successfully treat...
Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s,...
The aim of this retrospective study is to evaluate the efficacy and safety of intravenous immune glo...
Background: Patients with juvenile dermatomyositis (JDM) often present strong exercise intolerance a...
This thesis describes studies in the field of juvenile dermatomyositis (JDM), a chronic inflammatory...
Juvenile dermatomyositis is an autoimmune disease seen in children, which causes typical skin change...
The objective of this study is to describe the benefit of 20 % subcutaneous infusions of immunoglobu...
juvenile dermatomyositis is a chronic multisystemic disease. It is believed to be of autoimmune aeti...
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease, which usually presents wit...
Objective. Juvenile dermatomyositis (DM) is a chronic inflammatory myopathy of childhood primarily a...
The case of a 56-year-old woman, with a previous history of systemic lupus erythematosus (SLE), late...
The impact of duration of untreated symptoms in children with juvenile dermatomyositis (JDM) on clin...
Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already o...
The myositis syndromes include polymyositis, dermatomyositis (DM), necrotizing myopathy, inclusion b...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
To report clinical and immunologic aspects of a case with inclusion body myositis successfully treat...
Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s,...
The aim of this retrospective study is to evaluate the efficacy and safety of intravenous immune glo...
Background: Patients with juvenile dermatomyositis (JDM) often present strong exercise intolerance a...
This thesis describes studies in the field of juvenile dermatomyositis (JDM), a chronic inflammatory...
Juvenile dermatomyositis is an autoimmune disease seen in children, which causes typical skin change...
The objective of this study is to describe the benefit of 20 % subcutaneous infusions of immunoglobu...
DOI